Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS)
Solubility:Chloroform, DMSO, Methanol
Melting Point:149-154°C
Method for Determining Identity:Proton NMR (DMSO-d6 , CD3OD, & CDCl3) Spectroscopic and Mass Spectrometric AnalysisStability
TLC Conditions:As Reported
Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at 4°C. Stable for 6 months. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Light sensitive and hygroscopic.
Important Note:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
